GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Alzamend Neuro ALZN · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.42

+0.71%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Alzamend Neuro

Our reporting

We have not reported on Alzamend Neuro yet.

Next results

8 Dec 2026

Due on 8 Dec 2026. Analysts expect earnings of -0.23 a share.

Past results

Reported against what analysts expected

10 Sept 20269 Sept 202622 Jul 202611 Mar 20269 Dec 202510 Sept 2025
Earnings per share-0.68-1.28-0.74-0.58-0.30-1.28
Forecast-0.56-0.56-0.67-0.53-0.83-3.69

Key events

  1. 12 May 20259-to-1 reverse split
  2. 16 Jul 202410-to-1 reverse split
  3. 31 Oct 202315-to-1 reverse split
  4. 15 Jun 2021Listed

Alzamend Neuro in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.